Table 2.
Tissue | Tissue-/Tumor Classification | TWI | OHI | NIR-PI | StO2 |
---|---|---|---|---|---|
CA | #CA: (y)pT1-(y)pT2 vs. (y)pT3-(y)pT4 | (0.78/0.68) | (0.59/0.56) | (0.32/0.2) * | (0.37/0.31)0.061 |
- | #CA: ypT1-ypT2 vs. ypT3-ypT4 | (0.79/0.65) * | (0.46/0.56) | (0.35/0.14) * | (0.38/0.31) |
CA vs. HM | CA ((y)pT) vs. HM | (0.76/0.65) * | (0.59/0.42) *** | (0.22/0.26) | (0.34/0.24) *** |
- | CA (pT) vs. HM | (0.76/0.63) ** | (0.65/0.44) *** | (0.2/0.26) | (0.34/0.23) ** |
- | CA (ypT) vs. HM | (0.76/0.69)0.082 | (0.55/0.39) ** | (0.3/0.32) | (0.34/0.26) ** |
- | pT1-pT2 CA vs. HM | (0.67/0.62) | (0.68/0.46) ** | (0.19/0.27) | (0.35/0.26)0.055 |
- | ypT1-ypT2 CA vs. HM | (0.79/0.69) * | 0.46/0.33) | (0.35/0.32)0.093 | (0.38/0.24) *** |
- | pT3-pT4 CA vs. HM | (0.76/0.64) * | (0.6/0.43) ** | (0.21/0.24) | (0.31/0.23) * |
- | ypT3-ypT4 CA vs. HM | (0.65/0.71) | (0.56/0.42) * | (0.14/0.31) ** | (0.31/0.27) |
AD | #AD vs. HM (from (y)pT1-(y)pT2) | (0.71/0.66) | (0.55/0.4) * | (0.32/0.31) | (0.33/0.26) |
- | #AD vs. HM (from (y)pT3-(y)pT4) | (0.71/0.65) | (0.55/0.43) * | (0.32/0.27) | (0.33/0.24) * |
- | #AD vs. HM (from ypT) | (0.71/0.69) | (0.55/0.39) * | (0.32/0.32) | (0.33/0.26) |
- | AD vs. HM | (0.71/0.65) | (0.55/0.42)0.052 | (0.32/0.27) | (0.33/0.24) * |
- | #AD vs. ypT1-ypT2 CA | (0.71/0.79) | (0.55/0.46) | (0.32/0.35) | (0.33/0.38) |
- | #AD vs. HM (from ypT1-ypT2) | (0.71/0.69) | (0.55/0.33) * | (0.32/0.32) | (0.33/0.24) * |
- | #AD vs. HM (from ypT3-ypT4) | (0.71/0.71) | (0.55/0.42) * | (0.32/0.31) | (0.33/0.27) |